Danaher Co. (NYSE:DHR) Position Reduced by United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund reduced its position in shares of Danaher Co. (NYSE:DHR) by 22.8% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 116,176 shares of the conglomerate’s stock after selling 34,360 shares during the quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s holdings in Danaher were worth $32,299,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of DHR. CarsonAllaria Wealth Management Ltd. acquired a new position in Danaher during the second quarter worth about $25,000. nVerses Capital LLC acquired a new position in shares of Danaher in the 2nd quarter worth approximately $25,000. MFA Wealth Advisors LLC bought a new stake in shares of Danaher in the 2nd quarter worth approximately $51,000. Financial Connections Group Inc. bought a new stake in Danaher during the second quarter worth approximately $51,000. Finally, Western Pacific Wealth Management LP bought a new position in shares of Danaher in the first quarter valued at $55,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

DHR has been the subject of several research reports. Raymond James reduced their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. StockNews.com raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Wednesday, November 6th. Bank of America boosted their price target on shares of Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. KeyCorp lifted their price objective on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 23rd. Finally, Barclays decreased their target price on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $287.16.

Insider Activity at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the transaction, the senior vice president now owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR opened at $241.47 on Thursday. Danaher Co. has a 52 week low of $200.36 and a 52 week high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The business’s 50-day simple moving average is $263.88 and its 200-day simple moving average is $260.77. The firm has a market cap of $174.41 billion, a price-to-earnings ratio of 46.08, a P/E/G ratio of 4.40 and a beta of 0.85.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same period last year, the business posted $2.02 EPS. Danaher’s revenue was up 3.1% compared to the same quarter last year. As a group, equities research analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s payout ratio is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.